Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$61K Hold
229
0.01% 232
2020
Q4
$67K Hold
229
0.01% 211
2020
Q3
$54K Hold
229
0.01% 227
2020
Q2
$45K Sell
229
-74
-24% -$13.8K 0.01% 241
2020
Q1
$56K Hold
303
0.01% 225
2019
Q4
$51K Hold
303
0.01% 254
2019
Q3
$40K Hold
303
0.01% 238
2019
Q2
$37K Buy
+303
New +$36K 0.01% 251

Other funds holding AMED

Tompkins Financial's AMED Position: Q1 2021 in Review

Tompkins Financial held its Amedisys (AMED) position steady in Q1 2021 at 229 shares worth $61K. The position accounts for 0.01% of the portfolio, ranked #232.

Tompkins Financial first reported a position in AMED in Q2 2019 and has held it in 8 quarters since. The position peaked at $67K in Q4 2020. 388 funds tracked by Wall St. Rank hold AMED as of Q1 2021.

  • Tompkins Financial held 229 shares of Amedisys worth $61K as of Q1 2021.
  • Tompkins Financial left its Amedisys share count unchanged in Q1 2021.
  • Amedisys made up 0.01% of Tompkins Financial's portfolio in Q1 2021, its #232 holding.
  • Tompkins Financial first reported a position in Amedisys in Q2 2019 and has held it in 8 quarters since.
  • Tompkins Financial's Amedisys position peaked at $67K in Q4 2020.
  • 388 funds tracked by Wall St. Rank held Amedisys as of Q1 2021.

Based on Tompkins Financial's 13F filing for Q1 2021, filed 9 Jun 2021.